Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experiencedoi:10.3390/cancers15174353RENAL cell carcinomaLOG-rank testRETROSPECTIVE studiesSURVIVAL analysis (Biometry)KAPLAN-Meier estimatorPROGRESSION-free survival...
These treatments usually don’t work well for renal cell carcinoma. In some cases, your doctor may still prescribe them to ease your symptoms or if other treatments haven’t worked. Talk with them about these options and how they might make you feel. Scientists also are looking for new ...
Renal cell carcinoma: novel treatments for advanced disease E Huland,H Heinzer - 《Current Opinion in Urology》 被引量: 0发表: 2003年 VHL, the story of a tumour suppressor gene Early inactivation of VHL is commonly seen in clear-cell renal cell carcinoma (ccRCC), and insights gained from...
Renal Cell Carcinoma Abstract ImportanceRenal cell carcinoma (RCC) is a common malignancy, with an estimated 434 840 incident cases worldwide in 2022. In the US, it is the sixth most common cancer among males and ninth among females. ObservationsClear cell RCC is the most comm...
Treatment for renal cell carcinoma (RCC) has improved dramatically over the last decade, shifting from high-dose cytokine therapy in combination with surgical resection of tumors to targeted therapy, immunotherapy, and combination therapies. However, cur
Renal cell carcinoma is the 14th most common cancer worldwide. It is a heterogeneous group of histopathological entities, of which the most common is clear cell renal cell carcinoma. Approximately 20–30% of patients present initially with metastatic disease and an additional 20% will progress afte...
Renal Cell and Urothelial Carcinoma: Biomarkers for New Treatments Therapies for genitourinary malignancies have evolved considerably in the past five years. Combination treatment targeting biologically relevant immune and angiogenic pathways is improving patient survival in metastatic renal cell carcin... AL...
The development of treatments using drugs that target specific biological pathways, such as inhibitors of vascular endothelial growth factor and rapamycin pathways, have shown promise as an alternative therapy for patients with metastatic renal cell carcinoma.Rini...
Systemic therapy in metastatic renal cell carcinoma. World J Urol. 2016:1e10.Bedke J, Gauler T, Grunwald V, Hegele A, Herrmann E, Hinz S, Janssen J, Schmitz S, Schostak M, Tesch H, Zastrow S, Miller K (2017) Systemic therapy in metastatic renal cell carcinoma. World J Urol 35(2...
Renal cell carcinoma (RCC) is characterized by (a) lack of early warning signs, which results in a high proportion of patients with metastases at the time of diagnosis; (b) protean clinical manifestations; and (c) resistance to radiotherapy and chemotherapy. The estimates of new diagnoses and...